Publication

Alpha-synuclein as a Potential Biomarker for Parkinson’s Disease and Other Synucleinopathies: Gaps, Challenges, and Opportunities

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Alpha-synuclein as a Potential Biomarker for Parkinson’s Disease and Other Synucleinopathies: Gaps, Challenges, and Opportunities

Chat with Graph Search

A novel allosteric GCase modulator prevents Tau accumulation in GBA1WT and GBA1L444P/L444P cellular models

Epidemicity conditions in spatial models of infectious diseases

Self-driving microscopy detects the onset of protein aggregation and enables intelligent Brillouin imaging

Clinical Significance of the 5T;12TG Genotype in Pediatric CFSPID: A Retrospective Study

Structural basis of BAK sequestration by MCL-1 in apoptosis

A Longitudinal and Reproducible Anti-coactivation Pattern Between the Cerebellum and the Ventral Tegmental Area Relates to Apathy in Schizophrenia

Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic

From Nano to Macro An overview of the IEEE Bio Image and Signal Processing Technical Committee

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies

Capturing the heterogeneity of alpha-synuclein pathology in synucleinopathies

Disentangling Multiple System Atrophy - Structural insights from alpha-synuclein fibrils and tissue pathology

Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy

Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment

Development and clinical validation of computational imaging biomarkers for neurodegenerative diseases

Simulating the progression of brain structural alterations in Parkinson's disease

Targeting TDP-43 Proteinopathies in Neurodegeneration by its Native-State Stabilization

Pathological substrate of memory impairment in multiple system atrophy

3D in vitro modeling of the exocrine pancreatic unit using tomographic volumetric bioprinting

Comparative Analysis of Total Alpha-Synuclein (alpha SYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified alpha SYN Proteoforms

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders